BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 28052845)

  • 1. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.
    Barry E; Roberts S; Oke J; Vijayaraghavan S; Normansell R; Greenhalgh T
    BMJ; 2017 Jan; 356():i6538. PubMed ID: 28052845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis.
    Kaur G; Lakshmi PVM; Rastogi A; Bhansali A; Jain S; Teerawattananon Y; Bano H; Prinja S
    PLoS One; 2020; 15(11):e0242415. PubMed ID: 33216783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.
    Roberts S; Barry E; Craig D; Airoldi M; Bevan G; Greenhalgh T
    BMJ Open; 2017 Nov; 7(11):e017184. PubMed ID: 29146638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for type 2 diabetes: a short report for the National Screening Committee.
    Waugh NR; Shyangdan D; Taylor-Phillips S; Suri G; Hall B
    Health Technol Assess; 2013 Aug; 17(35):1-90. PubMed ID: 23972041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for type 2 diabetes: literature review and economic modelling.
    Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
    Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of clinical and biochemical profile of prediabetic subject in Bangladesh, attending in BIRDEM and results of intervention by lifestyle modification, metformin, and DPP4 inhibitor.
    Barua M; Pathan F; Nabi MU; Kabir M
    Diabetes Metab Syndr; 2019; 13(2):1603-1608. PubMed ID: 31336528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.
    Bulatova N; Kasabri V; Qotineh A; Al-Athami T; Yousef AM; AbuRuz S; Momani M; Zayed A
    Diabetes Metab Syndr; 2018 May; 12(3):257-267. PubMed ID: 29221717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
    Perez A; Alos VA; Scanlan A; Maia CM; Davey A; Whitaker RC; Foster GD; Ackermann RT; O'Brien MJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):320-327. PubMed ID: 26597415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.
    Mishu MP; Uphoff E; Aslam F; Philip S; Wright J; Tirbhowan N; Ajjan RA; Al Azdi Z; Stubbs B; Churchill R; Siddiqi N
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013281. PubMed ID: 33591592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: a randomised controlled trial.
    Sampson M; Clark A; Bachmann M; Garner N; Irvine L; Howe A; Greaves C; Auckland S; Smith J; Turner J; Rea D; Rayman G; Dhatariya K; John WG; Barton G; Usher R; Ferns C; Pascale M;
    BMC Med; 2021 Aug; 19(1):183. PubMed ID: 34407811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Belsti Y; Enticott J; Azumah R; Tay CT; Moran L; Ma RCW; Joham AE; Laven J; Teede H; Mousa A
    Diabetes Metab Syndr; 2024 Mar; 18(3):102970. PubMed ID: 38442646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Vander Schaaf EB; Riley S; Allison BA; Middleton JC; Baker C; Ali R; Voisin CE; LeBlanc ES
    JAMA; 2022 Sep; 328(10):968-979. PubMed ID: 36098720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2015 Jan; 38(1):51-8. PubMed ID: 25336746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening with HbA1c identifies only one in two individuals with diagnosis of prediabetes at oral glucose tolerance test: findings in a real-world Caucasian population.
    Chilelli NC; Cosma C; Ragazzi E; Burlina S; Zaninotto M; Plebani M; Lapolla A
    Acta Diabetol; 2014 Oct; 51(5):875-82. PubMed ID: 25192952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis.
    Sharma M; Beckley N; Nazareth I; Petersen I
    BMJ Open; 2017 Oct; 7(10):e017260. PubMed ID: 29084794
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.